We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Zachary L. Stamm
Zachary L. Stamm
Products
PRODUCTS
Global Treat Srl
Zachary L. Stamm
Price:
$117.00
View
Tolmar, Inc.
Michael A. Charles
and
Zachary L. Stamm
Price:
$117.00
View
Tolmar, Inc.
Zachary L. Stamm
Price:
$117.00
View
Lyocontract GmbH
Zachary L. Stamm
Price:
$117.00
View
Ionetix Corp.
Zachary L. Stamm
Price:
$117.00
View
Prescription Alternatives, Inc.
Zachary L. Stamm
Price:
$117.00
View
Prescription Alternatives, Inc.
Zachary L. Stamm
Price:
$117.00
View
Tolmar Inc.
Zachary L. Stamm
Price:
$117.00
View
Abraxis Bioscience LLC
Jamie L. Dion
and
Zachary L. Stamm
Price:
$117.00
View
Lincare Inc.
Zachary L. Stamm
Price:
$117.00
View
View All Products by Zachary L. Stamm
Upcoming Events
21
Apr
CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health
26
Apr
MAGI's Clinical Research vConference — Spring 2021
06
May
The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next
12
May
Extractables and Leachables: 101
25
May
How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
EMA Reviews GSK’s and Vir’s VIR-7831 for COVID-19
Hensler Surgical Technologies Earns CE Mark for Bone-Fusion Device
Eli Lilly Asks FDA to Nix EUA for Bamlanivimab Alone
Alimetry Earns CE Mark for Wearable Gastric Disease Diagnostic
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
